EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reshaping the Immune Microenvironment by Targeting DKK1 to Enhance Combination Immunotherapy Efficacy in Head and Neck Squamous Cell Carcinoma

Fei Wang, Minzhu Yan, Xuelin Dong, Zhijun Zhang, Pin Dong, Xinwei Chen

Frontiers in Bioscience-Landmark · 17.06.2026 · 31 (6)

DOI: 10.31083/fbl50766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 17.06.2026. Verfasst von Fei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Shanghai General Hospital of Nanjing Medical University, 200080 Shanghai, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Intercellular Signaling Peptides and Proteins, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Head and neck squamous cell carcinoma (HNSCC) is a common malignancy with high morbidity and mortality. Despite advances in immunotherapy, including the advent of immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1), only a subset of patients achieves significant benefit. This study aimed to evaluate the prognostic significance of Dickkopf-related protein 1 (DKK1), a potential modulator of the tumor immune microenvironment (TME), and to assess the therapeutic impact of combining DKK1 inhibition with ICIs.

Methods

Data from The Cancer Genome Atlas (TCGA) and a clinical cohort of 62 patients with HNSCC from Shanghai General Hospital were used to analyze DKK1 expression and its association with prognosis and immune cell infiltration. Tumor immune organoids were constructed by co-culturing tumor and immune cells from patient samples to mimic the TME and evaluate the effects of anti-DKK1 therapy. A preclinical mouse model using the MOC2 (mouse oral carcinoma 2) cell line was also used to test the therapeutic efficacy of combined anti-DKK1 and anti-PD1 treatment. Immune cell composition was analyzed using immunohistochemistry, immunofluorescence, and flow cytometry.

Results

High DKK1 expression was found to correlate with poor patient prognosis and an immunosuppressive TME, characterized by reduced CD8+ T cell infiltration and increased myeloid-derived suppressor cells (MDSCs). In tumor immune organoids, anti-DKK1 treatment reduced organoid growth. In vivo, combined anti-DKK1 and anti-PD1 treatment led to significantly greater tumor growth inhibition compared to monotherapies, increased CD8+ T cell activity, and decreased MDSC levels, thereby creating an immune-stimulatory environment.

Conclusions

DKK1 drives immune suppression in HNSCC and represents a promising therapeutic target. Tumor immune organoids offer a robust platform for studying tumor-immune interactions and evaluating combination immunotherapies. Combining anti-DKK1 and anti-PD1 treatment approaches has the potential to enhance antitumor immunity and improve outcomes in patients with HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentIntercellular Signaling Peptides and ProteinsHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckImmunotherapyImmune Checkpoint InhibitorsHumansAnimalsMiceFemaleMaleCell Line, TumorPrognosisMiddle Aged

Stichwörter der Autor:innen

Dickkopf-related protein 1immune checkpoint inhibitorssquamous cell carcinoma of head and necktumor microenvironment

Substanzen

Intercellular Signaling Peptides and ProteinsDKK1 protein, humanImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Otolaryngology, Head and Neck Surgery, Shanghai General Hospital of Nanjing Medical University, 200080 Shanghai, China.
  • Department of Otolaryngology, Head and Neck Surgery, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, 200021 Shanghai, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, F., Yan, M., Dong, X., Zhang, Z., Dong, P., & Chen, X. (2026). Reshaping the Immune Microenvironment by Targeting DKK1 to Enhance Combination Immunotherapy Efficacy in Head and Neck Squamous Cell Carcinoma. Frontiers in Bioscience-Landmark, 31(6). https://doi.org/10.31083/fbl50766

Vancouver

Wang F, Yan M, Dong X, Zhang Z, Dong P, Chen X. Reshaping the Immune Microenvironment by Targeting DKK1 to Enhance Combination Immunotherapy Efficacy in Head and Neck Squamous Cell Carcinoma. Frontiers in Bioscience-Landmark. 2026;31(6). doi:10.31083/fbl50766

BibTeX
@article{Wang2026,
  author = {Wang, Fei and Yan, Minzhu and Dong, Xuelin and Zhang, Zhijun and Dong, Pin and Chen, Xinwei},
  title = {Reshaping the Immune Microenvironment by Targeting DKK1 to Enhance Combination Immunotherapy Efficacy in Head and Neck Squamous Cell Carcinoma},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  volume = {31},
  number = {6},
  doi = {10.31083/fbl50766}
}
Kostenlos starten →